Enhanced Immunoreactivity of TIMP-2 in the Stromal Compartment of Tumor as a Marker of Favorable Prognosis in Ovarian Cancer Patients
暂无分享,去创建一个
T. Gansukh | B. Györffy | R. Matkowski | M. Zabel | H. Lage | P. Surowiak | A. Hałoń | P. Donizy | A. Maciejczyk | E. Nowak-Markwitz | M. Spaczyński